期刊文献+

乳腺癌放疗后继发冠状动脉疾病1例 被引量:2

One case of secondary coronary artery disease in breast cancer patient previously undergoing radiotherapy
下载PDF
导出
摘要 随着医学的发展进步,肿瘤治愈率有了显著提高,很多肿瘤患者能获得长期生存。然而,抗肿瘤治疗所产生的并发症也让患者付出了巨大代价。放疗是乳腺癌、淋巴瘤等恶性肿瘤的有效治疗手段,在对邻近心脏的肿瘤进行放疗时,会对心脏造成损伤引起放射性心脏病。接受多次放疗的肿瘤患者冠状动脉疾病等心血管疾病的发病率和死亡率明显升高,严重影响了患者的长期预后。本文报道1例女性乳腺癌患者,在放疗近10年后继发严重冠状动脉疾病,后行冠状动脉搭桥术及多次经皮冠状动脉介入(percutaneous coronary intervention,PCI)术,在放疗后20余年最终发展为心力衰竭。
出处 《中华老年多器官疾病杂志》 2018年第4期297-298,共2页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 国家自然科学基金(81770237)
  • 相关文献

参考文献3

二级参考文献52

  • 1戴晓萍,郭建萍.乳腺癌术后放疗病人血清心肌钙蛋白T测定与心脏损伤的研究[J].肿瘤学杂志,2005,11(4):292-293. 被引量:26
  • 2朱亚彬,刘志勇,李鸿雁.冠心病合并慢性阻塞性肺疾病患者冠状动脉旁路移植术疗效分析[J].中国胸心血管外科临床杂志,2006,13(2):82-85. 被引量:5
  • 3Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long term survivors of Hodgkin's disease treated with chest radiotherapy[J]. J Clin Oncol, 2004, 22(15):3139- 3148.
  • 4Kosmas C, Kallistratos MS, Kopterides P, et al. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study [J]. J Cancer Res Clin Oncol, 2008, 134(1):75 -82.
  • 5Sail MW, Tomita M, Ledbetter I J, et al. Capecitabine-related cardiotoxicity: recognition and management[J].J Support Oncol, 2008, 6(1) :41-48.
  • 6Altena R, Perik PJ, van Veldhuisen DJ, et al. Cardiovascular toxicity caused by cancer treatment: strategies for early detection[J].Lancet Oncol, 2009,10(4) :391-399.
  • 7Armenian SH, Bhatia S. Chronic health conditions in childhood cancer survivors:is it all treatment related-or do genetics play a role? [J]. J Gen lntern Med, 2009, 24 (Suppl 2):S395-S400.
  • 8Grise MA, Massullo V, Jani S. et al. Five-year clinical follow up after intracoronary radiation: results of a randomized clinical trial[J]. Circulation, 2002,105 (23) : 2737-2740.
  • 9Apter S, Shemesh J, Raanani P, et al. Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tornography detection and clinical correlation[J]. Coron Artery Dis, 2006, 17(2): 145- 151.
  • 10Sahz LB, Clarke S, Diaz Rubio E, et al. Bevacizumab in combination with oxaliplatin based chemotherapy as first line therapy in metastatic colorectal cancer: a randomized phase Ⅲ study[J].J Clin Oncol, 2008, 26(12):2013- 2019.

共引文献5

同被引文献30

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部